Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lynch

Showing results (891-900 of 929) with videos related to

Pageof 93
Sort By:
Journal of the National Cancer Institute|February 19, 2004
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityAsad Umar, C Richard Boland, Jonathan P Terdiman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
JAMA|September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortalitySusan M Domchek, Tara M Friebel, Christian F Singer, et al.
International Journal of Cancer|June 30, 2005
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCarey A Cullinane, Jan Lubinski, Susan L Neuhausen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2011
Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.
Breast Cancer Research : BCR|March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriersEitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.
Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Cancer Research|July 9, 2009
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriersTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
Plos One|February 15, 2013
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility allelesFrancisco Javier Gracia-Aznarez, Victoria Fernandez, Guillermo Pita, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.
Pageof 93

Showing results (891-900 of 929) with videos related to

Sort By:
Pageof 93
Journal of the National Cancer Institute|February 19, 2004
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityAsad Umar, C Richard Boland, Jonathan P Terdiman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
JAMA|September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortalitySusan M Domchek, Tara M Friebel, Christian F Singer, et al.
International Journal of Cancer|June 30, 2005
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCarey A Cullinane, Jan Lubinski, Susan L Neuhausen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2011
Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.
Breast Cancer Research : BCR|March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriersEitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.
Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Cancer Research|July 9, 2009
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriersTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
Plos One|February 15, 2013
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility allelesFrancisco Javier Gracia-Aznarez, Victoria Fernandez, Guillermo Pita, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.
Pageof 93